9      0

Virtual ACRP 2021

COVID01Jan13 - Sponsor Oversight of Decentralized Clinical Trials


Jan 13, 2021 11:00am ‐ Jan 13, 2021 12:00pm



Credits: None available.

Description

Explore decentralized clinical trials (DCT) and the oversight role of the sponsor. During COVID-19, many trials have been modified and changed to account for the inability to interact with subjects in person and many organizations have moved to a decentralized architecture. Session participants will: understand the regulations pertaining to decentralized clinical trials, learn the perceived benefits and challenges of a DCT, and discuss remote monitoring of DCTs.

Learning Objectives:
  • Understand the regulations pertaining to decentralized clinical trials.
  • Learn the perceived benefits and challenges of a DCT.
  • Discuss remote monitoring of DCTs.

Speaker(s):

  • Eric Pittman, MBA, Program Division Director, U.S. Food and Drug Administration

Credits

  • 1.00 - ACRP Credits

You must be logged in and own this session in order to post comments.

Regina Ingram
4/6/21 6:11 pm

Excellent

Regina Ingram
4/6/21 6:12 pm

Excellent